so the Nepal journal of epidemiology.….published 12 months ago.
Right. It’s certainly true pandemic disrupted non Covid treatment clinical trials especially early on in pandemic but the impact not equal everywhere and Australia by and large has managed to keep running trials quite well. If I assume posting this paper is an attempt to excuse the lack of trial progress in iconic trial 6 months after ethics approval would I be pretty warm?
Impact of COVID-19 on clinical trials, page-3
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 14.0¢ | 11.0¢ | $559.0K | 4.481M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6612 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 99714 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |